The good news about Johnson & Johnson getting approval for their Janssen COVID-19 vaccine is it opened up a lot more appointments. Over 70,000 of the one-shot doses were sent to New Jersey after the FDA granted emergency authorization use.
If there’s any bad news, and none of it is really bad, it’s the efficacy rate is lower than the Pfizer and Moderna vaccines but those were tested in trials before the mutations were out. Had they been tested at the same time, experts say the rates would have been similar.
I received the one-shot J&J vaccine on Monday. With it being the newest vaccine and receiving the protection all at once, people have been wondering about side effects.